Case and Research Letters
Verruciform Xanthoma Associated with Reactivation of Epstein-Barr Virus
Xantoma verruciforme asociado a reactivación de virus de Epstein-Barr
Leído
9701
Vecesse ha leído el artículo
3115
Total PDF
6586
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 32 | 7 | 39 |
| 2025 5 | 174 | 39 | 213 |
| 2025 4 | 167 | 25 | 192 |
| 2025 3 | 169 | 23 | 192 |
| 2025 2 | 150 | 42 | 192 |
| 2025 1 | 127 | 26 | 153 |
| 2024 12 | 117 | 40 | 157 |
| 2024 11 | 95 | 72 | 167 |
| 2024 10 | 81 | 45 | 126 |
| 2024 9 | 88 | 28 | 116 |
| 2024 8 | 122 | 103 | 225 |
| 2024 7 | 97 | 48 | 145 |
| 2024 6 | 121 | 56 | 177 |
| 2024 5 | 83 | 57 | 140 |
| 2024 4 | 83 | 44 | 127 |
| 2024 3 | 71 | 38 | 109 |
| 2024 2 | 72 | 45 | 117 |
| 2024 1 | 65 | 38 | 103 |
| 2023 12 | 68 | 33 | 101 |
| 2023 11 | 76 | 61 | 137 |
| 2023 10 | 97 | 44 | 141 |
| 2023 9 | 71 | 47 | 118 |
| 2023 8 | 51 | 29 | 80 |
| 2023 7 | 82 | 46 | 128 |
| 2023 6 | 57 | 24 | 81 |
| 2023 5 | 77 | 36 | 113 |
| 2023 4 | 66 | 25 | 91 |
| 2023 3 | 68 | 24 | 92 |
| 2023 2 | 70 | 19 | 89 |
| 2022 1 | 52 | 40 | 92 |
| 2022 12 | 68 | 34 | 102 |
| 2022 11 | 32 | 43 | 75 |
| 2022 10 | 28 | 30 | 58 |
| 2022 9 | 20 | 59 | 79 |
| 2022 8 | 22 | 51 | 73 |
| 2022 7 | 24 | 49 | 73 |
| 2022 6 | 37 | 36 | 73 |
| 2022 5 | 53 | 42 | 95 |
| 2022 4 | 67 | 44 | 111 |
| 2022 3 | 81 | 76 | 157 |
| 2022 2 | 42 | 35 | 77 |
| 2021 1 | 49 | 69 | 118 |
| 2021 12 | 28 | 55 | 83 |
| 2021 11 | 52 | 70 | 122 |
| 2021 10 | 64 | 66 | 130 |
| 2021 9 | 38 | 42 | 80 |
| 2021 8 | 72 | 42 | 114 |
| 2021 7 | 50 | 49 | 99 |
| 2021 6 | 29 | 39 | 68 |
| 2021 5 | 45 | 40 | 85 |
| 2021 4 | 60 | 67 | 127 |
| 2021 3 | 57 | 29 | 86 |
| 2021 2 | 65 | 35 | 100 |
| 2020 1 | 45 | 18 | 63 |
| 2020 12 | 35 | 18 | 53 |
| 2020 11 | 30 | 27 | 57 |
| 2020 10 | 35 | 9 | 44 |
| 2020 9 | 33 | 11 | 44 |
| 2020 8 | 26 | 17 | 43 |
| 2020 7 | 27 | 17 | 44 |
| 2020 6 | 36 | 22 | 58 |
| 2020 5 | 26 | 24 | 50 |
| 2020 4 | 35 | 29 | 64 |
| 2020 3 | 24 | 20 | 44 |
| 2020 2 | 5 | 2 | 7 |
| 2020 1 | 4 | 10 | 14 |
| 2019 12 | 8 | 5 | 13 |
| 2019 11 | 4 | 8 | 12 |
| 2019 10 | 0 | 3 | 3 |
| 2019 9 | 8 | 3 | 11 |
| 2019 8 | 4 | 3 | 7 |
| 2019 7 | 4 | 4 | 8 |
| 2019 6 | 6 | 16 | 22 |
| 2019 5 | 5 | 47 | 52 |
| 2019 4 | 2 | 10 | 12 |
| 2019 3 | 2 | 9 | 11 |
| 2019 2 | 2 | 3 | 5 |
| 2019 1 | 2 | 1 | 3 |
| 2018 12 | 0 | 7 | 7 |
| 2018 11 | 1 | 3 | 4 |
| 2018 10 | 3 | 0 | 3 |
| 2018 3 | 2 | 1 | 3 |
| 2018 2 | 40 | 3 | 43 |
| 2018 1 | 62 | 3 | 65 |
| 2017 12 | 48 | 10 | 58 |
| 2017 11 | 46 | 2 | 48 |
| 2017 10 | 52 | 3 | 55 |
| 2017 9 | 49 | 6 | 55 |
| 2017 8 | 76 | 5 | 81 |
| 2017 7 | 63 | 11 | 74 |
| 2017 6 | 78 | 8 | 86 |
| 2017 5 | 89 | 2 | 91 |
| 2017 4 | 69 | 8 | 77 |
| 2017 3 | 61 | 9 | 70 |
| 2017 2 | 53 | 3 | 56 |
| 2016 1 | 40 | 7 | 47 |
| 2016 12 | 52 | 7 | 59 |
| 2016 11 | 77 | 7 | 84 |
| 2016 10 | 76 | 10 | 86 |
| 2016 9 | 117 | 13 | 130 |
| 2016 8 | 68 | 10 | 78 |
| 2016 7 | 37 | 4 | 41 |
| 2016 6 | 7 | 9 | 16 |
| 2016 5 | 7 | 4 | 11 |
| 2016 4 | 4 | 12 | 16 |
| 2016 3 | 3 | 8 | 11 |
| 2016 2 | 5 | 8 | 13 |
| 2015 1 | 9 | 10 | 19 |
| 2015 12 | 7 | 6 | 13 |
| 2015 11 | 21 | 11 | 32 |
| 2015 10 | 21 | 11 | 32 |
| 2015 9 | 17 | 7 | 24 |
| 2015 8 | 8 | 4 | 12 |
| 2015 7 | 108 | 16 | 124 |
| 2015 6 | 78 | 24 | 102 |
| 2015 5 | 50 | 14 | 64 |
| 2015 4 | 43 | 9 | 52 |
| 2015 3 | 31 | 3 | 34 |
| 2015 2 | 36 | 10 | 46 |
| 2015 1 | 45 | 6 | 51 |
| 2014 12 | 40 | 7 | 47 |
| 2014 11 | 33 | 9 | 42 |
| 2014 10 | 39 | 17 | 56 |
| 2014 9 | 22 | 14 | 36 |
| 2014 8 | 38 | 11 | 49 |
| 2014 7 | 43 | 8 | 51 |
| 2014 6 | 40 | 8 | 48 |
| 2014 5 | 35 | 15 | 50 |
| 2014 4 | 33 | 6 | 39 |
| 2014 3 | 41 | 11 | 52 |
| 2014 2 | 41 | 8 | 49 |
| 2014 1 | 41 | 6 | 47 |
| 2013 12 | 41 | 16 | 57 |
| 2013 11 | 18 | 9 | 27 |
| 2013 10 | 19 | 3 | 22 |
| 2013 9 | 34 | 4 | 38 |
| 2013 8 | 19 | 4 | 23 |
| 2013 7 | 8 | 2 | 10 |
| 2013 6 | 2 | 1 | 3 |
Mostrar todo
